Prognosis of Primary Mucosal Penile Melanoma: A Series of 19 Dutch Patients and 47 Patients from the Literature
Albertus N. van Geel, Madelon N.A. van der Aa(Erasmus MC Cancer Institute), Alexander M.M. Eggermont(University Medical Center Utrecht), Michael A. den Bakker(Erasmus MC), Johannes H.W. de Wilt(Radboud University Nijmegen), Simon Horenblas(The Netherlands Cancer Institute), Bin B. R. Kroon, Wolter J. Mooi(The Netherlands Cancer Institute), Wim J. Kirkels(Erasmus MC)
Cited by 89
Related Papers
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
|New England Journal of Medicine|2011|7.7k
Final Version of 2009 AJCC Melanoma Staging and Classification
|Journal of Clinical Oncology|2009|4.6k
Melanoma staging: Evidence‐based changes in the American Joint Committee on Cancer eighth edition cancer staging manual
|CA A Cancer Journal for Clinicians|2017|2.3k
Adjuvant Pembrolizumab versus Placebo in Resected Stage III Melanoma
|New England Journal of Medicine|2018|1.9k